A detailed history of Arizona State Retirement System transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Arizona State Retirement System holds 32,329 shares of BBIO stock, worth $856,395. This represents 0.01% of its overall portfolio holdings.

Number of Shares
32,329
Previous 30,857 4.77%
Holding current value
$856,395
Previous $781,000 5.38%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$23.91 - $31.3 $35,195 - $46,073
1,472 Added 4.77%
32,329 $823,000
Q2 2024

Aug 05, 2024

BUY
$23.0 - $31.04 $49,933 - $67,387
2,171 Added 7.57%
30,857 $781,000
Q1 2024

May 07, 2024

BUY
$27.35 - $40.45 $101,331 - $149,867
3,705 Added 14.83%
28,686 $886,000
Q4 2023

Jan 24, 2024

SELL
$24.02 - $43.89 $3,675 - $6,715
-153 Reduced 0.61%
24,981 $1.01 Million
Q3 2023

Nov 06, 2023

BUY
$16.89 - $35.01 $6,519 - $13,513
386 Added 1.56%
25,134 $662,000
Q2 2023

Aug 01, 2023

BUY
$13.29 - $18.01 $69,865 - $94,678
5,257 Added 26.97%
24,748 $425,000
Q1 2023

Apr 27, 2023

BUY
$7.17 - $18.55 $4,782 - $12,372
667 Added 3.54%
19,491 $323,000
Q4 2022

Feb 07, 2023

BUY
$6.74 - $11.52 $5,142 - $8,789
763 Added 4.22%
18,824 $143,000
Q3 2022

Nov 07, 2022

BUY
$7.94 - $12.36 $476 - $741
60 Added 0.33%
18,061 $180,000
Q2 2022

Jul 28, 2022

BUY
$5.21 - $12.14 $10,868 - $25,324
2,086 Added 13.11%
18,001 $163,000
Q1 2022

May 04, 2022

SELL
$7.34 - $17.16 $16,324 - $38,163
-2,224 Reduced 12.26%
15,915 $162,000
Q4 2021

Feb 04, 2022

SELL
$11.38 - $53.41 $1,820 - $8,545
-160 Reduced 0.87%
18,139 $303,000
Q3 2021

Nov 12, 2021

BUY
$46.87 - $64.24 $3,655 - $5,010
78 Added 0.43%
18,299 $858,000
Q2 2021

Aug 02, 2021

BUY
$46.47 - $63.93 $140,664 - $193,516
3,027 Added 19.92%
18,221 $1.11 Million
Q1 2021

May 06, 2021

BUY
$55.47 - $72.35 $842,811 - $1.1 Million
15,194 New
15,194 $936,000

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $3.93B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.